Forward Pharma A/S ADR | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.18 |
Market Cap |
$47.42 M |
Shares Outstanding |
47.54 M |
Public Float |
- |
Address |
Østergade 24A Copenhagen CR 1100 Denmark |
Employees | - |
Website | http://www.forward-pharma.com |
Updated | 07/08/2019 |
Forward Pharma is a biopharmaceutical company, which engages in the research and production of medicinal treatment for multiple sclerosis and psoriasis. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 1, 2005 and is headquartered in Copenhagen, Denmark. |